(Q37783364)

23 August 2017

title

GP130 cytokines and bone remodelling in health and disease (English)

1 reference

23 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797312

2 July 2024

1

Natalie A. Sims

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797312

2 July 2024

author name string

Nicole C. Walsh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797312

2 July 2024

language of work or name

1 reference

1 August 2010

1 reference

full work available at URL

23 August 2017

published in

BMB Reports

1 reference

23 August 2017

volume

43

1 reference

23 August 2017

issue

8

1 reference

23 August 2017

page(s)

513-523

1 reference

Receptor recognition by gp130 cytokines

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

2 July 2024

2

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex

2 July 2024

3

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

The ciliary neurotrophic factor receptor alpha component induces the secretion of and is required for functional responses to cardiotrophin-like cytokine

2 July 2024

4

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Molecular cloning and expression of an IL-6 signal transducer, gp130

2 July 2024

5

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation

2 July 2024

6

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

2 July 2024

7

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130

2 July 2024

8

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption

2 July 2024

9

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Cardiotrophin-1 Is an Osteoclast-Derived Stimulus of Bone Formation Required for Normal Bone Remodeling

2 July 2024

10

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.

2 July 2024

11

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

SOST/sclerostin, an osteocyte-derived negative regulator of bone formation

2 July 2024

12

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction

2 July 2024

13

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Serum level of CNTF is elevated in patients with amyotrophic lateral sclerosis and correlates with site of disease onset

2 July 2024

14

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids

2 July 2024

15

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

An immunoluminometric assay for cardiotrophin-1: a newly identified cytokine is present in normal human plasma and is increased in heart failure

2 July 2024

16

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.

2 July 2024

17

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

The role of IL-6 type cytokines and their receptors in bone

2 July 2024

18

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption

2 July 2024

19

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Immunohistochemical localization of selected early response genes expressed in trabecular bone of young rats given hPTH 1-34

2 July 2024

20

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

2 July 2024

21

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.

2 July 2024

22

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Ciliary neurotrophic factor inhibits bone formation and plays a sex-specific role in bone growth and remodeling

2 July 2024

23

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells

2 July 2024

24

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer

2 July 2024

25

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation.

2 July 2024

26

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

gp130-Mediated Signaling Is Necessary for Normal Osteoblastic Function in Vivo and in Vitro

2 July 2024

27

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Interleukin-11: a new cytokine critical for osteoclast development

2 July 2024

28

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.

2 July 2024

29

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Interleukin-11 receptor signaling is required for normal bone remodeling

2 July 2024

30

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation

2 July 2024

31

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia

2 July 2024

34

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice

2 July 2024

35

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system

2 July 2024

37

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

2 July 2024

38

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

SOST is a target gene for PTH in bone

2 July 2024

39

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Imbalanced gp130-dependent signaling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression

2 July 2024

40

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome

2 July 2024

41

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

gp130 signaling in bone cell biology: multiple roles revealed by analysis of genetically altered mice.

2 July 2024

42

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals

2 July 2024

43

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Sib pair linkage and association studies between bone mineral density and the interleukin-6 gene locus

2 July 2024

44

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenopausal Japanese women

2 July 2024

45

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Stimulation of interleukin-6 production of periodontal ligament cells by Porphyromonas endodontalis lipopolysaccharide

2 July 2024

46

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Detection of interleukin-6 in human dental pulp and periapical lesions

2 July 2024

47

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Interleukin-11 and IL-17 and the pathogenesis of periodontal disease

2 July 2024

48

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation

2 July 2024

49

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Immunohistochemical localization of oncostatin M in epithelialized apical periodontitis lesions

2 July 2024

50

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Measurement of gp130 cytokines oncostatin M and IL-6 in gingival crevicular fluid of patients with chronic periodontitis

2 July 2024

51

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Serum levels of oncostatin M (a gp 130 cytokine): an inflammatory biomarker in periodontal disease

2 July 2024

52

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis

2 July 2024

53

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis

2 July 2024

54

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Activated T lymphocytes support osteoclast formation in vitro

2 July 2024

55

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis

2 July 2024

56

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis

2 July 2024

57

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation

2 July 2024

59

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Rheumatic diseases: the effects of inflammation on bone

2 July 2024

60

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Interleukin-6 as a key player in systemic inflammation and joint destruction.

2 July 2024

61

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis

2 July 2024

62

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model

2 July 2024

63

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

2 July 2024

64

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Amelioration of arthritis in two murine models using antibodies to oncostatin M.

2 July 2024

65

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis

2 July 2024

66

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair

2 July 2024

67

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Interleukin-6 modulates production of T lymphocyte–derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis

2 July 2024

68

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti-interluekin-6 receptor antibody

2 July 2024

69

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses

2 July 2024

70

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

The "enthesis organ" concept: why enthesopathies may not present as focal insertional disorders

2 July 2024

71

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Imaging the joint and enthesis: insights into pathogenesis of psoriatic arthritis

2 July 2024

72

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

The concept of a "synovio-entheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond

2 July 2024

73

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Histopathologic changes at "synovio-entheseal complexes" suggesting a novel mechanism for synovitis in osteoarthritis and spondylarthritis

2 July 2024

74

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis

2 July 2024

75

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Dickkopf-1 is a master regulator of joint remodeling

2 July 2024

76

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis

2 July 2024

77

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity

2 July 2024

78

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis

2 July 2024

79

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Pathogenesis and management of pain in osteoarthritis.

2 July 2024

80

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritis

2 July 2024

81

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Mechanism of proteoglycan aggregate degradation in cartilage stimulated with oncostatin M.

2 July 2024

82

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity

2 July 2024

83

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging

2 July 2024

84

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Role of a LIF antagonist in LIF and OSM induced MMP-1, MMP-3, and TIMP-1 expression by primary articular chondrocytes.

2 July 2024

85

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

IL-1beta induction of IL-6 and LIF in normal articular human chondrocytes involves the ERK, p38 and NFkappaB signaling pathways

2 July 2024

86

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown

2 July 2024

87

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation

2 July 2024

88

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Osteoblasts display receptors for and responses to leukemia-inhibitory factor

2 July 2024

89

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

2 July 2024

90

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells

2 July 2024

91

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

The distribution of receptors for the pro-inflammatory cytokines interleukin (IL)-6 and IL-8 in the developing human fetus.

2 July 2024

92

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression

2 July 2024

93

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.

2 July 2024

94

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.

2 July 2024

95

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism

2 July 2024

96

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF

2 July 2024

97

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

Leukaemia inhibitory factor (lif) is expressed in hypertrophic chondrocytes and vascular sprouts during osteogenesis

2 July 2024

98

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.8.513

2 July 2024

Identifiers

1 reference

23 August 2017

1 reference